These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats]. Han LP; Yu DM; Xie Y Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2513-5. PubMed ID: 19080636 [TBL] [Abstract][Full Text] [Related]
29. Novel protein kinase C-beta isoform selective inhibitor JTT-010 ameliorates both hyper- and hypoalgesia in streptozotocin- induced diabetic rats. Sasase T; Yamada H; Sakoda K; Imagawa N; Abe T; Ito M; Sagawa S; Tanaka M; Matsushita M Diabetes Obes Metab; 2005 Sep; 7(5):586-94. PubMed ID: 16050952 [TBL] [Abstract][Full Text] [Related]
30. Diabetes-induced cerebrovascular dysfunction: role of poly(ADP-ribose) polymerase. Arrick DM; Sharpe GM; Sun H; Mayhan WG Microvasc Res; 2007 Jan; 73(1):1-6. PubMed ID: 16982071 [TBL] [Abstract][Full Text] [Related]
31. Comparative study of peripheral neuropathy and nerve regeneration in NOD and ICR diabetic mice. Homs J; Ariza L; Pagès G; Verdú E; Casals L; Udina E; Chillón M; Bosch A; Navarro X J Peripher Nerv Syst; 2011 Sep; 16(3):213-27. PubMed ID: 22003936 [TBL] [Abstract][Full Text] [Related]
32. The proinflammatory cytokine, interleukin-17A, augments mitochondrial function and neurite outgrowth of cultured adult sensory neurons derived from normal and diabetic rats. Habash T; Saleh A; Roy Chowdhury SK; Smith DR; Fernyhough P Exp Neurol; 2015 Nov; 273():177-89. PubMed ID: 26321687 [TBL] [Abstract][Full Text] [Related]
33. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits. Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114 [TBL] [Abstract][Full Text] [Related]
34. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor. Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455 [TBL] [Abstract][Full Text] [Related]
35. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism. Cameron NE; Cotter MA Diabetes Metab Res Rev; 2002; 18(4):315-23. PubMed ID: 12203947 [TBL] [Abstract][Full Text] [Related]
36. PARP inhibition restores erectile function by suppressing corporal smooth muscle apoptosis in diabetic rats. Li WJ; Zhou J; Li B; Wang H; Peng YB; Wang Z J Sex Med; 2011 Apr; 8(4):1072-82. PubMed ID: 21235725 [TBL] [Abstract][Full Text] [Related]
37. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Obrosova IG; Drel VR; Pacher P; Ilnytska O; Wang ZQ; Stevens MJ; Yorek MA Diabetes; 2005 Dec; 54(12):3435-41. PubMed ID: 16306359 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 attenuates the development of experimental diabetes-related neuropathy. Andriambeloson E; Baillet C; Vitte PA; Garotta G; Dreano M; Callizot N Neuropathology; 2006 Feb; 26(1):32-42. PubMed ID: 16521477 [TBL] [Abstract][Full Text] [Related]